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Conclusions: Although GPIIb/lUa blockade in the absence of heparin may 
not significantly prolong the ACT, it appears to potentiate heparin effect in a 
dose dependent manner. The increment in ACT w~th c7E3 was proportional 
to the degree of underlying anticoagulation (as reflected by the baseline 
ACT), with a possible interaction at high heparin doses. Thus, increased 
bleeding with c7E3 may be avoidable if the hepadn dose is lowered. The 
effect of c7E3 on TEG variables implies that ACT does not measure the time 
to onset of fibrin formation, but rather the time to attainment ofa certain clot 
strength. 
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~6~ Intravenous Nitroglycerin Causing Heparin 
Resistance 
Naseem Jalfrani, Wet Can, Vasant Ranade, John Sombsrg. Finch 
University of Health Sciences/The Chicago Medical School, Division of 
Cardiology, North Chicago, IL 
The existence of an interaction between itroglycerin (TNG) and hoparin (H) 
has remained controversial. To evaluate this interaction, Sprague Dawiey 
rats (5 in each group, n = 50) were anesthetized and activated clotting time 
(ACT) detemnlned before and following H. H, 70 units/kg bolus followed by 5 
units/hr was given and ACT increased from 60 -4- 11 to 135 ± 38 sen (p < 
0.01 ), at I hour. ACT remained prolonged with H infusion for 4 hre (135 ± 38 
seohr 1. 128 ± 25 sec hr 2,139 + 25 sen hr 3, and 155 ~ 35 sec hr 4). TNG 
IV in a propylene glycol solution was administered 0.2 mg bolus foflowed by 
0.1 mg/hr. H caused ACT to increase from 43 ± 6 to 100 :l: 4 sen and then 
TNG caused ACT to decrease at 1,2 and 3 hrs, 64 ± 11,55 ± 12 and 53 -4- 4 
sec respectively. TNG without propylene glycol caused a s;milar a~e~J.~t~on 
of H effect. Both high (0.20 m0. and low (0.04 mg) boluses of TNG every 
3 min attenuated ACT prolongation by H as well as shortening tho time to 
attenuation of H effect. TNG (0.2 mg) decreased ACT from 183 :t: 28 to 132 
± 12 5 min, 123 ± 10 10 rain, and 119 ± 3 15 rein; while with TNG (0.04 rag) 
ACT decreased from 138 ± 22 to 134.4- 2 at 5 rein, 143 4- 2 15 min, 116 ± 
22 20 rain, and 92 ± 11 at 25 min. Saline in amounts equal to the volume 
of TNG was given over 3 hrs with no change in ACT. In this in vivo model 
TNG & H show a definite interaction with the prolongation i ACT caused by 
H decreased by concomitant administration ofTNG. 
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~ " ]  Comparisen Between Low Molecular Weight 
Heparin and Standard Heparin in Unstable Angina 
Luis Correia, Fabio Esteves, Mario Rocha, J. Pericles Estavas. Cardiology 
Service of Portuguese Hospital, Salvador, Bahia, Brazil 
Standard hep3rin, by intravenous route (IVH), is often used in the treatment 
of patients with acute isehemic syndromes and reduces the number of is- 
chemics events in unstable angina patients. However, its adminlsbation is
hampered by the need for repeated aPTT measurements and dosage ad- 
justments. We tested the hypothesis that the c!inical outcome and safety of 
subcutaneous low molecular weight hepadn (LMWH), which does not re- 
quire repeated monitoring of aPTT, are similar to those of standard heparin 
in patients (P) with unstable angina. We also compared the pharmacological 
effect of subcutaneous tandard heparin (SCH) with IVH, Tha number of 
revascaiarization (PTCA, CABG), hemorrhagic events (at 1 week), as well 
as aP'Fr at baseline, 6 hours post-bclus (aPTT1), and at 12 hours intervals 
thereafter (aPTT2-6) were obtained in 350 patients (g0% Breunwald's Class 
Ill/B), mean age 67 4- 11 years. All received IVH 5000 IU as an initial bolus 
and 200 mg ASP. daily. Seventy P (LMWH) received 15000 antI-Xa U, every 
12 h; 110 P (SCH) 12500-17500 IU, every 12 h and 170 P (IVH) about 1200 
IU/h. Only SCH and IVH dosages were adjusted by an algorithm to keep 
aPTT 1.5-3.0 times control. Results: 
LMWH SCH tVH p 
aFT'T'l (POSt.bolus) (s) 55 :L: 23" 64 4- 40 98 4-18 <0.0001 
oPTT2-6 (mean) (s) 40 ~- 06 ° 80 ~- 40 88 4. 38 0.093 
Therapeutic Level (%) - 57.3 5,5.9 0.967 
SupflUhempoutic Level (%) - 21.8 24.1 0.607 
Events (PTCA, CABG) (%) 5.7 5.5 4.7 0.922 
. 1 ~  (%) 5.7 6.4 7.1 0.924 
*Not compared in statistical nalylds 
Except for the first measured aPTT 6h post-bolus, thanzpautic level can 
be ac~iGved with subcutaneous administration of standard heparin as well 
as intravenous route. There was no ddferenoe in clinical outcome and herin 
orrt~a0tc evonta hotweet~ patients ireatud with IVH, SCH and LMWH. Thus, 
LMWH may be morn I:ractlcal and equany etficaclous aftemative tu ~e use 
ol IVH In ucanable angine pa~.,~. 
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i '8"6~ A Randomized Comparison of Higher and Lower 
Dose Aspirin on Collagen-Induced Platelet 
Aggregation 
DaLi Feng, Carol McKerma, Jaime Mufillo, Izabelia Lipinska, Murray 
A. Mittleman, James E. Muller, Geoftrey H, Tofler, Institute for Prevention of 
Cardiovascular Disease, Cardiology Division, Deaconess Hospital, Harvard 
Medical School, Boston, MA 
The optimal dosage of aspidn for protection against cardiovascular disease 
is uncertain, particularly in different clinical settings. Since heavy exertion 
has been shown to trigger myocardial infarction, and an increase in piatelet 
aggregation with exercise has been reported, we compared the effects of two 
doses of aspidn (81 mg, n = 19 and 325 rag, n = 21) on piatelet aggregability 
before and after treadmill exercise. 
In a randomized, ouble-blind, parallel study of 40 healthy males, Born og- 
gregemetry was performed to determine the lag time to aggregation following 
exposure to 0.19 mg/ml collagen (CLT). A longer CLT indicates reduced re. 
sponsiveness. Both 81 mg and 325 mg aspirin significantly increased the CLT 
compared to that observed pre-aspirin, however the 325 mg increased the 
CLT to a greater extent (p < 0.05). Prior to aspirin, exercise was associated 
with a shortening of CLT. This increase in respo,se was abolished by beth 
doses of aspirin. 
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Conclusion: While both 01 mg and 325 mg aspirin significantly inhibited 
platelet reactivity to collagen, a greater inhibition was observed with 325 rag. 
Since collagen Is an important platelet ogonist in vive, the clinical significance 
of this dosage-relatsd ifference warrants further study. 
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~0~ Emergency Coronary Bypass or  Angioplsety in 
Patients With Electromeehanicel Dissociation or 
Refractory Ventricular Fibrillation: Enhanced 
Survival With Left Ventricular Venting 
Fayaz A. Shawl, Alain Efstratlou, Femando Lapatina, Susan Hoff, 
Kathy Doughsrty. Washington Adventist Hospital, Takoma Park, MD 
Left ventricular (LV) distension during ventdcuiar fibrillation (VF) or eleo- 
tremechanlcal dissociation (EMD) can reduce subondocardial perfuslon and 
thus impair LV performance. Despite the institution of percutaneous car- 
diopulmonery bypass support (PCP$) dudng cardiac arrest (CA), 25 tots 
remained in refractory VF (21 pts) or EMD (4 pts). All pts had complete loss 
of LV ejection during or shortly after coronary intervention (9 pts) or routine 
angiogrsphy (16 pts). Fourteen pts (Group I) had paroutaneous LV venting 
(8-10F pigtail catheter in LV) pdor to emergency bypass surge,'y (N : 11) 
or after emergency angioplasty (N ,. 3) and outcomes were compared to 11 
10ts who went directly to bypass surgery and did not hove LV venting (Group 
2). Baseline clinical and angiographic haracteristics were similar for both 
groups. Pts had PCPS established uring VF or EMD with a mean time to 
PCPS of 18 ± 11 mtn (17 ± 14 rain for Group 1 and 19 + 8 min for Group 
2). Group 1 had LV venting prior to surgery (N ,, 11) or alter ongioplasty (N 
= 3) and Group 2 was immediately Iransferred to suTge~f on PCPS without 
venting, Mean pulmonary artery pressure (MPAP) for both groups was (39 
± 4 mm Hg on PCPS. but MPAP dropped ~ 10:1:4 turn Hg in Group I pts 
after LV venting was inil~tod (p < 0.001). Overall suwivel was 44%. Smvivel 
for Group I was 71% vemt~ only 9% for Group 2 (o < 0.007). These data 
s~,~t  that LV venting can decrease LV distension and may ;,,,~,,~e sin. 
viral whon used as an edimct tu PCPS d, dng emergency b/pasa suq~e~ 
or ~,-,~p~ty th CA pts. 
